Bullish option flow detected in Eli Lilly (LLY) with 38,006 calls trading, 1.2x expected, and implied vol increasing over 1 point to 32.28%. Nov-24 700 calls and Nov-24 815 calls are the most active ...

Now, Eli Lilly is looking to lower that cost a little ... But the classic Zepbound was given with an auto-injector that ...

In a press release, drug giant Eli Lilly announced that it's releasing ... drug up to 50 percent savings compared to the preloaded auto-injection pens, which as NBC notes can cost $1,059 ...

Another issue for investors is that Eli Lilly adjusted its guidance for the year, now projecting its adjusted EPS to fall ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eli Lilly announced ... month through Lilly's direct-to-consumer website. You can also get 5-milligram single dose vials for ...

What would a Harris or Trump presidency mean for health care policy? Why did Eli Lilly’s Mounjaro and Zepbound sales miss expectations? And does Adam believe in ghosts? We talk about all that an ...

Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase ...

Key drugs from Johnson & Johnson and Eli Lilly stand to bolster their respective cases in competitive dermatology markets with new data readouts. J&J evaluated its Tremfya in patients with low ...

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products that claimed to contain tirzepatide, the main ingredient in its popular weight-loss medicine ...